LUYE PHARMA GROUP LTD.

Business Segments Luye Pharma Group Ltd.

Equities

2186

BMG570071099

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 09:08:37 11/09/2024 BST			5-day change	1st Jan Change
2.930 ^HKD	-1.01%		-2.33%	-21.45%

08-30	Citi Upgrades Luye Pharma to Buy From Sell; Price Target is HK$4	MT
08-28	Luye Pharma Group Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI

Sales 2023 by Business Segment

See more © MarketScreener.com

Sales 2023 by Geography

See more © MarketScreener.com

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Breakdown by Business Segment

Fiscal Period: December	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Pharmaceutical Products
Oncology Drugs						2.81B	2.24B	1.41B	2.31B	2.12B
Operating Income						1.56B	1.23B	691M	1.25B	867M
Central Nervous System Drugs						1.34B	1.4B	1.32B	1.32B	1.69B
Operating Income						477M	482M	470M	394M	596M
Cardio-Vascular System Drugs						1.04B	1B	1.43B	1.54B	1.69B
Operating Income						322M	382M	409M	472M	559M
Alimentary Tract and Metabolism Drugs						1B	733M	898M	632M	450M
Operating Income						418M	183M	93.31M	140M	120M
Others						159M	165M	137M	185M	188M
Operating Income						72.12M	52.01M	29.42M	61.24M	5.68M
Operating Income						-526M	-521M	-571M	-583M	-644M

Geographical Revenue Distribution History

Geographical breakdown of sales

Fiscal Period: December	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Mainland China						5.32B	4.51B	4.24B	5.03B	5.03B
Total Assets						4.56B	6.04B	7.25B	8.09B	10.11B
European Union						277M	243M	244M	309M	450M
Total Assets						1.56B	1.57B	1.33B	1.32B	1.33B
Total Assets						3.59B	2.46B	2.32B	2.43B	2.38B
Asia (Other than Chinese Mainland)						397M	505M	444M	342M	447M
Other Countries						364M	280M	275M	299M	217M
Total Assets						85.36M	103M	136M	54.34M	53.12M

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW